Industry: Medical Devices & Consumables
Published Date: 2026-03-27
Pages: 95 Pages
Report ld: 6383704
Request Sample
Customized Report
The global Heart Failure Devices market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
The goal of heart failure device treatment is to intervene in these three functional disorders. This usually includes repairing or improving heart structure through anatomical means, using electrophysiological techniques to manage arrhythmias, or enhancing myocardial contractility through mechanical support to improve the heart's pumping function. At the same time, since most heart failures start with left ventricular dysfunction, causing pulmonary congestion, heart failure patients may also experience respiratory failure. Therefore, mechanical support devices can also assist respiratory function and help relieve heart failure symptoms.
According to the treatment principle of the device, the existing heart failure devices on the market can be divided into three categories: mechanical assistance, electrical-related technology and structural improvement. In the future, with the influence of factors such as doctor recognition, accelerated population aging and improved affordability, the market for heart failure devices will further expand.
In 2025, the North America Heart Failure Devices market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
Major global manufacturers of Heart Failure Devices include Abbott, Medtronic, Jarvik Heart, Abiomed, Boston Scientific, Impulse Dynamics, SynCardia, Berlin Heart, Covia Medica, V-Wave, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Heart Failure Devices market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Heart Failure Devices sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Heart Failure Devices manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Heart Failure Devices product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Heart Failure Devices value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Heart Failure Devices Product Scope
1.2 Heart Failure Devices by Type
1.2.1 Global Heart Failure Devices Sales by Type (2021, 2025 & 2032)
1.2.2 Mechanical Assistance Type
1.2.3 Electrical Related Technology
1.2.4 Structural Improvement Type
1.3 Heart Failure Devices by Application
1.3.1 Global Heart Failure Devices Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 GradeⅠ- Ⅳ
1.3.3 Grade Ⅱ- Ⅳ
1.3.4 Grade Ⅲ -IV
1.4 Global Heart Failure Devices Market Estimates and Forecasts (2021-2032)
1.4.1 Global Heart Failure Devices Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Heart Failure Devices Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Heart Failure Devices Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Heart Failure Devices Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Heart Failure Devices Historical Market Scenario by Region (2021-2026)
2.2.1 Global Heart Failure Devices Sales Market Share by Region (2021-2026)
2.2.2 Global Heart Failure Devices Revenue Market Share by Region (2021-2026)
2.3 Global Heart Failure Devices Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Heart Failure Devices Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Heart Failure Devices Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Heart Failure Devices Market Size and Prospects (2021-2032)
2.4.2 Europe Heart Failure Devices Market Size and Prospects (2021-2032)
2.4.3 China Heart Failure Devices Market Size and Prospects (2021-2032)
2.4.4 Japan Heart Failure Devices Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Heart Failure Devices Historical Market Review by Type (2021-2026)
3.1.1 Global Heart Failure Devices Sales by Type (2021-2026)
3.1.2 Global Heart Failure Devices Revenue by Type (2021-2026)
3.1.3 Global Heart Failure Devices Average Price by Type (2021-2026)
3.2 Global Heart Failure Devices Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Heart Failure Devices Sales Forecast by Type (2027-2032)
3.2.2 Global Heart Failure Devices Revenue Forecast by Type (2027-2032)
3.2.3 Global Heart Failure Devices Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Heart Failure Devices
4 Global Market Size by Application
4.1 Global Heart Failure Devices Historical Market Review by Application (2021-2026)
4.1.1 Global Heart Failure Devices Sales by Application (2021-2026)
4.1.2 Global Heart Failure Devices Revenue by Application (2021-2026)
4.1.3 Global Heart Failure Devices Average Price by Application (2021-2026)
4.2 Global Heart Failure Devices Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Heart Failure Devices Sales Forecast by Application (2027-2032)
4.2.2 Global Heart Failure Devices Revenue Forecast by Application (2027-2032)
4.2.3 Global Heart Failure Devices Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Heart Failure Devices Applications
5 Competition Landscape by Players
5.1 Global Heart Failure Devices Sales by Player (2021-2026)
5.2 Global Top Heart Failure Devices Players by Revenue (2021-2026)
5.3 Global Heart Failure Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Heart Failure Devices revenue as of 2025
5.4 Global Heart Failure Devices Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Heart Failure Devices, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Heart Failure Devices, Product Type & Application
5.7 Global Key Manufacturers of Heart Failure Devices, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Heart Failure Devices Sales by Company
6.1.1.1 North America Heart Failure Devices Sales by Company (2021-2026)
6.1.1.2 North America Heart Failure Devices Revenue by Company (2021-2026)
6.1.2 North America Heart Failure Devices Sales Breakdown by Type (2021-2026)
6.1.3 North America Heart Failure Devices Sales Breakdown by Application (2021-2026)
6.1.4 North America Heart Failure Devices Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Heart Failure Devices Sales by Company
6.2.1.1 Europe Heart Failure Devices Sales by Company (2021-2026)
6.2.1.2 Europe Heart Failure Devices Revenue by Company (2021-2026)
6.2.2 Europe Heart Failure Devices Sales Breakdown by Type (2021-2026)
6.2.3 Europe Heart Failure Devices Sales Breakdown by Application (2021-2026)
6.2.4 Europe Heart Failure Devices Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Heart Failure Devices Sales by Company
6.3.1.1 China Heart Failure Devices Sales by Company (2021-2026)
6.3.1.2 China Heart Failure Devices Revenue by Company (2021-2026)
6.3.2 China Heart Failure Devices Sales Breakdown by Type (2021-2026)
6.3.3 China Heart Failure Devices Sales Breakdown by Application (2021-2026)
6.3.4 China Heart Failure Devices Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Heart Failure Devices Sales by Company
6.4.1.1 Japan Heart Failure Devices Sales by Company (2021-2026)
6.4.1.2 Japan Heart Failure Devices Revenue by Company (2021-2026)
6.4.2 Japan Heart Failure Devices Sales Breakdown by Type (2021-2026)
6.4.3 Japan Heart Failure Devices Sales Breakdown by Application (2021-2026)
6.4.4 Japan Heart Failure Devices Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Abbott
7.1.1 Abbott Company Information
7.1.2 Abbott Business Overview
7.1.3 Abbott Heart Failure Devices Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Abbott Heart Failure Devices Products Offered
7.1.5 Abbott Recent Development
7.2 Medtronic
7.2.1 Medtronic Company Information
7.2.2 Medtronic Business Overview
7.2.3 Medtronic Heart Failure Devices Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Medtronic Heart Failure Devices Products Offered
7.2.5 Medtronic Recent Development
7.3 Jarvik Heart
7.3.1 Jarvik Heart Company Information
7.3.2 Jarvik Heart Business Overview
7.3.3 Jarvik Heart Heart Failure Devices Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Jarvik Heart Heart Failure Devices Products Offered
7.3.5 Jarvik Heart Recent Development
7.4 Abiomed
7.4.1 Abiomed Company Information
7.4.2 Abiomed Business Overview
7.4.3 Abiomed Heart Failure Devices Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Abiomed Heart Failure Devices Products Offered
7.4.5 Abiomed Recent Development
7.5 Boston Scientific
7.5.1 Boston Scientific Company Information
7.5.2 Boston Scientific Business Overview
7.5.3 Boston Scientific Heart Failure Devices Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Boston Scientific Heart Failure Devices Products Offered
7.5.5 Boston Scientific Recent Development
7.6 Impulse Dynamics
7.6.1 Impulse Dynamics Company Information
7.6.2 Impulse Dynamics Business Overview
7.6.3 Impulse Dynamics Heart Failure Devices Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Impulse Dynamics Heart Failure Devices Products Offered
7.6.5 Impulse Dynamics Recent Development
7.7 SynCardia
7.7.1 SynCardia Company Information
7.7.2 SynCardia Business Overview
7.7.3 SynCardia Heart Failure Devices Sales, Revenue and Gross Margin (2021-2026)
7.7.4 SynCardia Heart Failure Devices Products Offered
7.7.5 SynCardia Recent Development
7.8 Berlin Heart
7.8.1 Berlin Heart Company Information
7.8.2 Berlin Heart Business Overview
7.8.3 Berlin Heart Heart Failure Devices Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Berlin Heart Heart Failure Devices Products Offered
7.8.5 Berlin Heart Recent Development
7.9 Covia Medica
7.9.1 Covia Medica Company Information
7.9.2 Covia Medica Business Overview
7.9.3 Covia Medica Heart Failure Devices Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Covia Medica Heart Failure Devices Products Offered
7.9.5 Covia Medica Recent Development
7.10 V-Wave
7.10.1 V-Wave Company Information
7.10.2 V-Wave Business Overview
7.10.3 V-Wave Heart Failure Devices Sales, Revenue and Gross Margin (2021-2026)
7.10.4 V-Wave Heart Failure Devices Products Offered
7.10.5 V-Wave Recent Development
7.11 Evaheart
7.11.1 Evaheart Company Information
7.11.2 Evaheart Business Overview
7.11.3 Evaheart Heart Failure Devices Sales, Revenue and Gross Margin (2021-2026)
7.11.4 Evaheart Heart Failure Devices Products Offered
7.11.5 Evaheart Recent Development
7.12 BrioHealth Solutions
7.12.1 BrioHealth Solutions Company Information
7.12.2 BrioHealth Solutions Business Overview
7.12.3 BrioHealth Solutions Heart Failure Devices Sales, Revenue and Gross Margin (2021-2026)
7.12.4 BrioHealth Solutions Heart Failure Devices Products Offered
7.12.5 BrioHealth Solutions Recent Development
7.13 Hanyu Medical
7.13.1 Hanyu Medical Company Information
7.13.2 Hanyu Medical Business Overview
7.13.3 Hanyu Medical Heart Failure Devices Sales, Revenue and Gross Margin (2021-2026)
7.13.4 Hanyu Medical Heart Failure Devices Products Offered
7.13.5 Hanyu Medical Recent Development
7.14 NewMed Medical
7.14.1 NewMed Medical Company Information
7.14.2 NewMed Medical Business Overview
7.14.3 NewMed Medical Heart Failure Devices Sales, Revenue and Gross Margin (2021-2026)
7.14.4 NewMed Medical Heart Failure Devices Products Offered
7.14.5 NewMed Medical Recent Development
7.15 Valgen Medtech
7.15.1 Valgen Medtech Company Information
7.15.2 Valgen Medtech Business Overview
7.15.3 Valgen Medtech Heart Failure Devices Sales, Revenue and Gross Margin (2021-2026)
7.15.4 Valgen Medtech Heart Failure Devices Products Offered
7.15.5 Valgen Medtech Recent Development
8 Heart Failure Devices Manufacturing Cost Analysis
8.1 Heart Failure Devices Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Heart Failure Devices
8.4 Heart Failure Devices Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Heart Failure Devices Distributors List
9.3 Heart Failure Devices Customers
10 Heart Failure Devices Market Dynamics
10.1 Heart Failure Devices Industry Trends
10.2 Heart Failure Devices Market Drivers
10.3 Heart Failure Devices Market Challenges
10.4 Heart Failure Devices Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Heart Failure Devices market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-27
Pages: 164
USD 4900.00
(Single User License)
The global market for Heart Failure Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 123
USD 3950.00
(Single User License)
The global Heart Failure Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 123
USD 2900.00
(Single User License)
The global Heart Failure Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 161
USD 4900.00
(Single User License)
The global Heart Failure Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 97
USD 4250.00
(Single User License)
The global market for Heart Failure Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 119
USD 3950.00
(Single User License)
The global market for Heart Failure Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 96
USD 2900.00
(Single User License)
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published Date: 2024-06-11
Pages: 123
USD 4350.00
(Single User License)
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published Date: 2024-06-11
Pages: 96
USD 2900.00
(Single User License)
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published Date: 2024-06-11
Pages: 152
USD 4900.00
(Single User License)
The global Heart Failure Devices market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-27
Pages: 164
The global market for Heart Failure Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 123
The global Heart Failure Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 123
The global Heart Failure Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 161
The global Heart Failure Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 97
The global market for Heart Failure Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 119
The global market for Heart Failure Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 96
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published: 2024-06-11
Pages: 123
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published: 2024-06-11
Pages: 96
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published: 2024-06-11
Pages: 152
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now